The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Abacavir
Abacavir · ABACAVIR SULFATE 20 mg/mL · Solution · Oral · Camber Pharmaceuticals, Inc.
NDC 31722-0562-24 · 240 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$125.48
Reported to Texas DSHS · 2026 annual filing · Hetero Labs Limited
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$15,038
87 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Hetero Labs LimitedIndiaanalysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA201107
- TE code
- AA
- Approval date
- Sep 26, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Abacavir (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Camber Pharmaceuticals, Inc. | ABACAVIR SULFATE 20 mg/mL | Jul 15, 2026 | Aug 12, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Abacavir — NDC 31722-0562-24," retrieved September 3, 2026, https://drugdashboards.com/drug/31722056224.
Free to cite with attribution — see how the data is put together.